Scarica l'app Stockscreener
9.88
0.10%
0.01
Dopo l'orario di chiusura:
9.88
Twelve Seas Investment Company Iii Borsa (TWLV) Ultime notizie
TWLV Should I Buy - Intellectia AI
symbol__ Stock Quote Price and Forecast - CNN
Twelve Seas Investment Company III 10-K: International SPAC Focus, Business Combination Strategy, and Risk Factors for 2025 - Minichart
Twelve Seas III (NASDAQ: TWLV) outlines $172.5M SPAC IPO and trust - Stock Titan
Twelve Seas Investment Company III Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
TWLV SEC FilingsTWELVE SEAS INVT CO III 10-K, 10-Q, 8-K Forms - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
Layoff Tracker: Vistagen, Evotec, Reckitt Benckiser Downsize, Collectively Affecting Hundreds - BioSpace
IRAB Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
TWLV Technical Analysis & Stock Price Forecast - Intellectia AI
TWLV Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TWLVR Stock Price, News & Analysis - Stock Titan
KingsRock Advisors Appoints Bob Foresman as Vice Chairman - citybiz
KingsRock Advisors Announces Additional Senior Hires, with Bob Foresman joining as a Vice Chairman - GlobeNewswire
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Hamburg Declaration: North Sea Countries Target 100 GW of Cross-Border Offshore Wind, Boost to Offshore Hydrogen - offshoreWIND.biz
450,000 Units of Twelve Seas Investment Company III are subject to a Lock-Up Agreement Ending on 11-JAN-2026. - marketscreener.com
Twelve Seas Investment Company III Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 9, 2026 - The Manila Times
Twelve Seas Investment Co III Announces Separate Trading of Shares and Rights - TradingView — Track All Markets
Nasdaq stock bundle splits so traders can buy its pieces alone - Stock Titan
SAMstream Launches AI Platform to Help Organizations of All Sizes Find and Bid on Government Contracts - The Manila Times
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution - The Manila Times
Terrestrial Energy to Participate in the 28th Annual Needham Growth Conference - The Manila Times
Bitfarms to Present at Needham Growth Conference in NYC - The Manila Times
RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Constellation Brands Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Definitive Healthcare to Present at the 28th Annual Needham Growth Conference - The Manila Times
iMDx Announces 'JPM Week” and 'BTIG Snowbird” Conference Participation - The Manila Times
Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis - The Manila Times
Crane NXT to Participate in the CJS Securities 26th Annual New Ideas for the New Year Conference - The Manila Times
Ethan Allen Announces Release Date for its Fiscal 2026 Second Quarter Results - The Manila Times
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation - The Manila Times
BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes - The Manila Times
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors - The Manila Times
Abivax Provides 2026 Corporate Outlook - The Manila Times
Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Diamondback Energy, Inc. Schedules Fourth Quarter 2025 Conference Call for February 24, 2026 - The Manila Times
Genelux Corporation Announces Proposed Public Offering of Common Stock - The Manila Times
Republic Power Group Limited Announces Receipt of a Bid Deficiency Notice from Nasdaq - The Manila Times
Crane Harbor Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing January 12, 2026 - The Manila Times
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP - The Manila Times
Amlan International Brings Gut Health and Feed Efficiency Innovation to IPPE 2026 - The Manila Times
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - The Manila Times
Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Bahamas.com Wins Caribbean’s Best Tourism Authority Website 2025 at World Travel Tech Awards - The Manila Times
Daily News - FinancialContent
Twelve Seas Investment Company III Announces Separate Trading for Class A Ordinary Shares and Rights Starting January 9, 2026 - Quiver Quantitative
Twelve Seas Investment Co III completes $172.5 million IPO and private placement By Investing.com - Investing.com
Twelve Seas Investment Co III Completes IPO and Private Placement - TradingView — Track All Markets
1.53%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):